Bilcare Research

[bilcareresearchtechnologies-blog]

Navigating the Way to Structural Packaging Innovation

The most notable innovation in packaging over the last 10 years has
 been the rise of flexible solutions across a wide variety of product categories. Flexible pouches can lower material requirements and reduce energy, printing, transportation, warehousing and other costs. They can shrink 
the brand’s environmental footprint. And they can help brands go to
market faster. But what happens to the brand equity you’ve built into a rigid bottle – that iconic shape, its familiar usability, the feeling that it belongs there, on the store shelf and in the shopper’s home? The label alone should never be your brand’s sole differentiator. When a packaging innovation takes away a familiar shape for your brand, it has to give something back that engages your consumers even more than before – an instantly recognizable advantage that’s desirable and proprietary. A classic example of this is baby food. When moms saw the familiar glass jar replaced by flexible pouches in the store, they immediately realized the advantages of a package that’s safer, easier to carry, less messy, and even more enjoyable for baby. For the purpose of feeding babies, the new flexible package was inherently more attractive to shoppers than the old glass jar. But what about another product category, where the advantages of flexible pharma packaging may not be so obvious? How do you bring a radical change to the shelf without getting bitten by shoppers who identify strongly with your old package?

Bringing Consumers Into the Design Process 
Ideally, shoppers should recognize your brand in-store, immediately understand the functional benefits of your new package, try it, and never miss the old bottle when they realize how much better your new pouch fits their lives. To make sure this happens, you need to get actual consumers involved as early as possible in the product development process and pharma packaging research. For example, we recently undertook a design exercise for bringing flexible packaging innovation to hand soaps, shower gels and other personal care products. The goal was to design a stand-up pouch that would benefit a well-known brand by lowering material and production costs while enabling easier recyclability. However, it could only succeed by appealing to consumers. We had to make the package easier to use while giving it a form that
is instantly recognizable both for its beauty and functional advantages – enabling it to become the next iconic expression of the brand’s values and equities. We sketched many pouch concepts – a handle for hanging, a shower-stall suction cup, a headstand pouch that dispenses from the base, a “bag in
 a bottle” concept with a rigid shell that accepts refill pouches, and many more. We also sketched many closures – snap-off, twist-off, pull-out, flip-up, and others. To evaluate these ideas, we turned to actual users as early as possible in the design process. That meant assembling pouches, 3D-printing closures and other parts, and getting fully functional prototypes into the hands of consumer/testers. Within two or three weeks of the project kickoff, we already had real-world consumers evaluating our first five working prototypes.

Whatever the project’s constraints, you need to continually validate each design iteration against what’s practical to manufacture. Setting Sail 
Don’t be afraid of your customers. They are not six-headed monsters. Let them help you. Don’t be afraid of your manufacturer. They’re not an unalterable whirlpool. Get in there and see if you can change the manufacturing flow just enough to make a difference for your brand. Brand change always involves risk, but the bigger risk is not changing. To discover your structural packaging innovation, with confidence, get everyone on board and set sail.

[bilcareresearchtechnologies-blog]

Pharma anti-counterfeit set to rise substantially

The pharmaceutical anti-counterfeiting technology market will almost double in the next few years, rising from $3.4bn last year to $6.5bn by 2020, says a new study. The global pharmaceutical anti-counterfeiting market will grow at a compound annual growth rate of 13.6 per cent from 2014 to 2020, dipping to a still healthy 9.5 per cent CAGR between 2020 and 2026.

he US and the EU dominated shares of the market in 2015. However, emerging markets will increase their market shares throughout the forecast period as the demand for such technologies will be greatest in areas where illegal counterfeiting is greatest. Africa, Asia and South America remain popular destinations for counterfeiting solutions, notes Visiongain, but the problem is now widespread in developed countries too. Much of the new legislation coming in over the next five years will be in the emerging national markets such as Brazil, India and Russia.

This year the barcodes submarket holds the highest proportion with a market share of 29.8 per cent, and will grow at a CAGR of 6.5 per cent from 2014-2020 and 2.7 per cent from 2020-2026. RFID will be the fastest growing submarket from 2014-2020 with a CAGR of 22.3 per cent.

The introduction of tougher criminal penalties for counterfeiters coupled with government involvement demanding e-pedigrees on all pharmaceutical products will help to expand the anti-counterfeit packaging and technologies market. The increasingly global pharmaceutical supply chain will also act as a catalyst for growth in this market.China and India, for example, are among the largest exporters of pharma products; therefore growth in the anti-counterfeiting technologies market of these two big economies will boost the global market.To implement anti-counterfeiting technologies on a global scale there must be cohesion between different national regulatory authorities, according to King.Cooperation between countries on an international level must improve – many are now working towards standardisation. There are many companies where there is forefront of delivering sustainable, affordable and packaging innovation solutions to customers globally. As the research driven organizations with single source capabilities follows a customer centric approach to fulfill packaging needs in the areas of pharmaceutical packaging, card solutions and specialty films.

[bilcareresearchtechnologies-blog]

NonClonableID Technologies by Bilcare providing counterfeit solutions

Counterfeiting has become the biggest nuisance of modern times. Counterfeiters have come up with newer tactics to produce fake counterparts of luxury items, consumer goods, electronics items etc. Even pharmaceutical and biotechnology industries have not been able to deter counterfeiting. However, in sensitive industries such as these two, counterfeiting can be a serious issue. Fake medicines or other clinical supplies can pose a grave danger to a person’s health. The existing anti-counterfeiting technologies are not effective enough to keep counterfeiting at bay. With breakthrough research and development in micro and nanotechnology, Bilcare Technologies has developed a first-of-its-kind technology – nonClonableID™. The solution enables products to be authenticated as they move through the supply chain to the end consumer.

BILCARE nonClonableID™ TECHNOLOGIES (nCID)

The nCiD packaging system comprises of tags with a unique materials-based “fingerprint” that is prohibitively difficult to replicate. These can be seamlessly integrated into any supply chain system, and through the use of Bilcare’s reader, one can provide secure authentication of any product. The solution provides a comprehensive anti-counterfeiting solution that also enables secure Track-n-Trace, leading to e-Pedigree of the products across the supply chain – from manufacturer to consumer. This technology innovatively exploits micro and nano-particulate materials together with their optical properties to provide a foolproof authentication solution.

Features of nonClonableID™

Unique fingerprints generated out of randomly distributed micro and nano particles

Machine-readable fingerprints enable an objective and reliable authentication process

Real-time authentication through hand-held portable readers

Fingerprints can be integrated with overt systems like barcodes/ RFID tags etc. and within any existing software/hardware infrastructure>

Proprietary scanning device scans the fingerprint and instantly communicates the encrypted information with a secure server through mobility platforms such as GPRS, 3G or Broadband.

Complete authentication report on a mobile or computer using robust web enterprise secured applications and data management at back-end

[bilcareresearchtechnologies-blog]

Anti-counterfeiting solutions by Bilcare Research

Counterfeiting takes place through various means and forms, including theft and unauthorized manufacturing. Specific methods can vary by product. For example, in the apparel industry, trim is known as the “currency of counterfeiting” that allows counterfeiters to add authentic detail to unauthorized product and consequently requires vigilant monitoring of inventories and usage. It is estimated that 5-7% of all world trade is in counterfeit goods, a problem affecting almost every sector from consumer and luxury goods through to pharma, automotive and defence.

Globally, counterfeiting has become a serious threat. Counterfeit products damage the reputation of brand owners, pose a real danger to the health and safety of consumers, and reduce the profits of legitimate players in the industry. Bilcare offers a foolproof end-to-end solution to combat this growing problem through the implementation of its nonClonableID™ technology.

Anti-counterfeiting solutions need to be customized to your particular product type. However, a number of best practices apply to all product types and should be included in your anti-counterfeiting program.

These include:

Working with trusted suppliers and partners

Verifying raw material and components for legitimacy

Monitoring and inspecting shipments of goods to confirm quantity and authenticity

Controlling production waste and the disposal of damaged and unusable goods

Establishing procedures for exit and wind-down operations

Bilcare Research implements brand security through nonClonableID™ tags that use a material matrix encoding unique to each tag. This makes it prohibitively difficult for counterfeiters to replicate the tags.

Our comprehensive anti-counterfeiting solution also enables secure Track-n-Trace and leads to e-Pedigree through the supply chain. Bilcare has a global customer base and customers comprise many of the largest global pharmaceutical companies viz. Bristol-Myers Squibb, Dr. Reddy’s, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, Teva to name a few. Bilcare has a strong customer base of over 1000 customers in over 100 countries worldwide. Bilcare is an organization made up of motivated people, who believe in going that extra mile to spread excellence and joy.

[bilcareresearchtechnologies-blog]

Bilcare chairman announcement

Dear Shareholders, Previous President of India, Late Dr. APJ Abdul Kalam regularly used to quote "You are never given a fantasy without the ability to make it work out". Dispatch of our ''focal point of incredibleness ''at Pune is reminiscent of our old affectionate recollections with Dr. Kalam. As we recall that him, we draw gigantic feeling of motivation and also desire. Motivation to remain against multifaceted difficulties as they rise and yearning to be an impactful pioneer in our part, while conquering all hindrances. Much sooner, Bilcare set up its worldwide foot shaped impressions in the created economy, it had a dream to be worldwide pioneer, and in doing as such, it sought after a fantasy that encapsulates Dr. Kalam's' thought. In numerous event, I had the chance to look for his instruct and favors wealth source with respect to inspiration, which thusly offered us in taking forward some of our development on medication some assistance with dispensing and ncID™ Technology. Bilcare dependably took a gander at pharma bundling from an investigative, research point, which not just offered us to be a pioneer in a few medication some assistance with dispensing advances additionally secured these developments with worldwide licenses, which thusly helped us to be on top of things, while making our blessing from heaven! Bilcare Research AG (BRAG), containing pharma, claim to fame and card bundling business in the US, Europe and now Asia, which constitute more than 80 % of Company's' aggregate income is ''Gaining Momentum'' to develop as key development driver for the Company, exhibiting solid turnover development and edge change in the ebb and flow year. Gloat's' Revenue has expanded from EUR 240 Mn. in (2011/12) to EUR 265 Mn. in (2014/15), current year, regardless of way out from bundling business worth EUR 40 Mn. Correspondingly, BRAG EBIDTA is up from EUR 8 Mn. in (2011/12) to EUR 27 Mn. in (2014/15) because of judicious technique execution, cost proficiency and realignment of business and items. Boast business having merged and collected authority position in the US and Europe, is presently hoping to grow and tap high potential Asian markets. Bilcare Research AG procured Bilcare Singapore pharma bundling resources and adjusted to its European and US plan of action as a characteristic strategy, furthermore to grow its client base in Mainland China, and other Asian markets, making Singapore as an Asian Hub. It is likewise conceivable to say that BRAG, a quickly leading so as to develop business is very much financed European saves money with stable reimbursement giving further driving force for development in deals and edges. As a major aspect of limit development plan to mix development and meet client prerequisite, BRAG is presently contributing 15 Million Euro at its assembling site Staufen, Germany, where Bilcare is been referred to for quite a long time as a solid and submitted accomplice in the therapist movies market. Our most recent two years abroad rebuilding exercise has launch to obvious result this year and this pattern should proceed in the following years. Bilcare keeps on contributing on R&D exercises and viably use its speculations made on formation of examination locales bringing about effective expansion of more up to date items, forms administrations and advances to its development portfolio. Amid the budgetary year, Bilcare documented 2 new Patent applications identified with its inventive items and advances and were allowed 9 Patents, before connected. Bilcare R&D got leap forward in growing light weight material that can have a great obstruction for ''Nuclear Radiation''. DRDO have taken their first model trial with this material and have put in a request for the same. Bilcare GCS timed 12.8% Revenue development with expansion of 14 new customers. ''Comparator Sourcing'' business expanded generously over a year ago, indicating 40% development. With development and expanding client necessity from the west, GCS opened showcasing workplaces in USA and UK to catch future open door. We anticipate that this business division will cross INR 100 Cr. by one year from now. Bilcare Technology made advances in stowing pharma and Government clients and critical pilot ventures. Discussing pharma, there was line incorporation venture for serialization administrations for essential, optional and tertiary level bundling for Biocon, including supply of auxiliary and tertiary marks. Additionally, we could execute serialization and track and follow according to DGFT and MoHFW command for optional and tertiary packs for Merck at Fulford India Ltd and Organ on India. An outlook change in Bilcare ncID Technology is relied upon to be unleashed with incitement of exceptionally capable technocrat; who alongside his ''new group'' is chipping away at go-to-the-business sector technique with client arranged arrangement offerings. Financials: Absolute Standalone Revenue for the year declined from INR 394.47 Cr. in (FY14) to INR 335.60 Cr. in (FY15). This loss of offers is basically by virtue of mash in working capital combined with misfortune/unfulfillment of requests, or as it were we needed to swear off requests close by because of crude material inaccessibility for said reasons. This brought about diminished EBIDTA of INR 25.29 Cr. in the present year, (FY15) from INR 57.49 Cr. of the earlier year, (FY14). Increment in deterioration from INR 67.81 Cr. in (FY14) to INR 105.52 Cr. in (FY15) brought about extra increment of INR 37.71 Cr. because of progress in Company's' demonstration 2013, bringing about Net Loss of INR 183.68 Cr. for the year, (FY15). Be that as it may, Revenue for the quarter finished, (Q4 FY15) remained at INR 90.48 Cr. as against INR 78.16 Cr. of the past quarter (Q3 FY15), demonstrating a development of 15.76% Complete Consolidated Revenue for the present year finished, (FY15) lessened to INR 2737.88 Cr. as against INR 3075.66 Cr. of the most recent year (FY14) with EBIDTA% insignificantly up from 8.35% to 8.44%. "Disappointment will never surpass me if my definition to succeed is sufficiently solid" this expression of Dr. Kalam is maybe most able, when I consider India Business. As you know, India Business in most recent two years in experiencing certain anxiety because of befuddle of money streams affecting crude material acquirement and meeting clients'' orders close by, subsequently our top and main concern has endured to a vast degree. We have strived difficult to meet our leaser duty – with just about 60% determination of obligation through different choices and structures admissible under managing an account system. We are sure to pivot headwinds, through our ceaseless, aggregate, antagonistic try, investigating every single conceivable alternative. With BRAG business hinting at obvious energy, close by India obligation under expedient determination, I am sure that your Company will soon turn out from avenue of its turbulent past to a superior and brilliant future in the coming monetary year. As I close, might I, in the interest of your Board of Directors and the workers of your Company, at the end of the day thank you for your proceeded with backing and support. Much thanks to you, Ladies and Gentlemen. Mohan H. Bhandari Administrator and Managing Directorat

[bilcareresearchtechnologies-blog]

Pharma Packaging and Innovation

The pharma bundling industry, however develop, is experiencing an ocean of progress. The advancement of this industry is attached to developments. Developing customer needs, novel prescriptions, propelling innovation, expanding cost weight, stringent regulations, and so forth., are driving advancement in pharma bundling. These elements, alongside various others, are assuming a crucial part in upgrading bundling usefulness. Aside from advancements, the significance of configuration has likewise climbed the bend for industry players. In this article, we look at the key patterns liable to shape the pharma bundling industry scene in 2015.

"As the pharmaceutical business presses toward more customized, delicate, and strong medications, the significance of bundling turns out to be considerably more critical." –Christopher Cassidy, VP (Sales and Marketing) – Pharmaceutical Packaging, Schott (July 2014)

Key Trends

Serialization and Anticounterfeiting Packaging: In our January 2014 blog entry, "The World of Pharma in 2014 – Serialization, Regulations, and Rising API Costs", we discussed the boundless predominance of fake medications, particularly in pharmerging markets, and the different regulations being embraced by governments to check their invasion. India's Directorate General of Foreign Trade (DGFT) orders the utilization of one of a kind numbers and standardized identifications on essential, optional, and tertiary bundling for simple following and following, a practice known as serialization, of all medications sent out from the nation. The command, which came into power in January 2011, should be completely executed by mid-2013. Be that as it may, because of resistance, the due date has been reached out to April 2015. The California ePedigree Law, which requires pharma makers and merchants to execute serialization, will probably become effective from January 2015.

Pharma organizations comprehensively have changed/are changing their bundling procedure to adjust to these regulations. Pfizer is actualizing serialization, all the more forcefully since 2012, for its whole bundling lines and offering suppliers some assistance with doing the same. Daiichi Sankyo is likewise accelerating usage to meet the January 2015 due date in the US.

"Inside Pfizer, there are some close term objectives we have to progress in the direction of. We are pushing ahead with the advancement of our IT undertaking arrangements and are reassessing the impact of the new law on our bundling lines' serialization plans."– Peggy Staver, Director – Product Integrity, Pfizer (March 2014)

"A sit back and watch methodology won't abandon us much time to execute a legitimate arrangement. Daiichi is evaluating prerequisites and recognizing choices now." –Stephen Kovary, Senior Director – Technical Operations, Daiichi Sankyo (March 2014)

"Rolling out improvements and including new or one of a kind components, for example, serialization, will unquestionably bring creation costs up in any environment." – Ryan O'Dell, Chief Marketing Officer, Safecor Health (March 2012)

Moreover, different advancements, for example, RFIDs, alter clear packs, 3D images, marks, and exceptional inks, can be utilized to battle fake drugs. In August 2014, analysts at the University of Michigan and in South Korea added to an extraordinary flimsy film with apparently imperceptible pictures. These photos are uncovered when they interact with human breath.

Albeit advantageous, these progressions require huge spending by medication makers. The inquiry is—in what manner will industry players utilize serialization and advantage from it?

Mechanization by Contract Packagers: With the presentation of stringent anticounterfeiting regulations and usage of serialization, pharma bundling prerequisites have turned out to be more confounded. Thus, pharma organizations are progressively robotizing bundling lines. In May 2014, Pfizer began utilizing a programmed, nondestructive rankle pack testing gadget. The gadget is prone to decrease the review cost prompting a general cost diminishment, which is commonly the rationale behind any sort of computerization.

"The mix of apply autonomy is changing the business, permitting adaptabilities, and in addition encouraging and associating, at a rate that was not already conceivable." – Fabio Trippodo, President, MG America (March 2014)

"We are seeing more demands to incorporate mechanical autonomy into bundling lines with or without track-and-follow abilities." – Kim Norris, Sales Project Coordinator, ESS Technologies (March 2014)

Senior-accommodating and Child-safe Packaging: With expanding offer of the elderly on the planet populace, pharma and bundling organizations are concentrating on senior-accommodating (SF) bundling internationally. As of late, organizations have dispatched a large group of SF holders and packs. In November 2014, Colbert Packaging propelled MedLock EZT, a patient-consistent bundling arrangement that is senior amicable and kid safe. It utilizes a locking system (patent pending) that is troublesome for kids to open and simple for grown-ups. By December 2013 report titled "World Population Aging 2013", the worldwide offer of more seasoned individuals (matured >60) will increment 10% amid 2013–2050, further expanding the requirement for SF bundling.

Alongside SF bundling, concentrate on youngster safe (CR) bundling has likewise expanded. Numerous organizations have propelled CR packs over the recent months. In October 2014, Romaco and Ecobliss presented Locked4Kids, a CR container box expressly intended to pack drugs. The container contains unique rankle plate, with little snares corner to corner to each other, which secure when pushed. With a specific end goal to evacuate the plate, both snares must be discharged all the while, which is an overwhelming errand for children.

Further, with new regulations being presented, the pattern is prone to increase in the coming years.

"By June 2015, when the new, skillet European Classification, Labeling, and Packaging of Chemical Substances Regulations, known as the CLP, become effective, more items should be pressed in kid safe compartments." –Stephen Wilkins, CEO, Child Safe Packaging Group (June 2014)

"It is compulsory for pharma organizations to take after investigative bundling techniques. Notwithstanding marking, bundling ought to address item needs, persistent accommodation, and item security. Recently, controllers are focusing on kid safe and easy to use bundling." – Chakravarthi AVPS, MD, Ecobliss India (November 2014)

Eco-accommodating Packaging: Although eco-accommodating and practical bundling is by all accounts losing influence, their significance does not wind down. With the always expanding natural concerns, drug producers and bundling organizations are continually concentrating on eco-accommodating bundling materials, strategies, and innovations. Pfizer is continually attempting to decrease its carbon foot shaped impression by expanding reusing of bundling materials and diminishing the measure of virgin materials utilized as a part of bundling. Another sample is of Eco Lips, a US-based lip care items maker, which presented its new natural lip emollients in biodegradable, compostable paper tubes in February 2014.

"The new Eco Tube will ideally be the start of a movement into feasible bundling for the whole lip medicine class." – Steve Shriver, CEO, Eco Lips (February 2014)

"The worldwide adaptable bundling industry is right now seeing an expanding requirement for supportable and eco-accommodating bundling, driven by nourishment, drink, individual consideration items, and pharmaceutical businesses." – Ashok Chaturvedi, Chairman and MD, Uflex (January 2014)

Talking Packaging: This is an innovation that empowers items to represent themselves. With the developing requirement for accommodation among buyers, the commonness of talking bundling (e.g., Rondo Pak's sight and sound container propelled in September 2014) in the pharma and nourishment businesses is rising. The container can be outfitted with a HD video screen, which can be utilized to grant utilization guidelines to purchasers, and for different applications. NFC-empowered bundling, created by VTT Technical Research Center of Finland in January 2012, for the outwardly debilitated is likewise a variation of talking bundling. At the point when a code interacts with a NFC-empowered gadget, a client can download the item and measurement data, which can be played back utilizing a telephone or PC.

In spite of the expanding cost weight, organizations lean toward "talking packs" to influence buyers, who effectively get pulled in by extravagant, innovation driven items.

Over the previous decade, wellbeing sustenances, for example, juices and protein bars, have recorded enormous development. Therefore, the pharma (particularly the OTC portion) and nourishment commercial ventures have focalized to frame pharmafoods—a fairly novel industry. The line of distinction—in different perspectives (counting bundling)— between the businesses has been weakened, with both confronting comparable difficulties. While the pharma business fights fake prescriptions, the sustenance business is confronted with wellbeing issues—obvious from the "horsemeat outrage" in 2013. In our September 2014 blog entry, "The Food Industry Supply Chain: Thoughts on Supplier Quality", we talked about wellbeing issues in the sustenance business. In the midst of expanding regulations and organization activities to battle fake medications, ought to nourishment retailers and sustenance industry controllers take after the stead o

[bilcareresearchtechnologies-blog]

Magictouch Anti-counterfeit Solution

Just about the most efficient strategies to battle counterfeiting should be to develop consciousness among buyers in so doing decreasing requires for reproductions.The actual Magictouch Anti-counterfeit Option makes it possible to develop consciousness towards counterfeits by giving buyers which has a trusted approach to certifying the authenticity regarding solutions and files.Using the non-reproducible Bubble Tag™ technological innovation by means of Prooftag, our own solution makes it possible to uniquely recognize each and every file or perhaps solution hence promising it's authenticity.The perfect solution involves official certifications regarding solutions and files by means of request of any Bubble Tag™ as well as account activation inside the databases. The actual Bubble Tag™ is usually a arbitrarily made marking which has a exclusive variety of pockets and a exclusive guide amount throughout alphanumeric and datamatrix formats. The moment a new Bubble Tag™ will be generated, it's image will be then considered plus the couple of ‘reference number/picture’ will be located right into a guaranteed authentication databases. On keeping a new Bubble Tag™ on a solution or perhaps file, it is activated inside the databases and turns into designed for proof over the web.We offer a new reading through technique, making use of optical visitors, which usually permit a new official authentication on the Bubble Tag™ in comparison with a new guide inside the authentication databases.Our Anti-counterfeit solution guarantees uniqueness, authenticity, ethics and traceability inside the pursuing problem areas: Record AuthenticationTogether with forgery within the increase, they have turn out to be almost impossible for recipients regarding files for you to identify initial real files coming from solid or perhaps artificial types.The actual Bubble Tag™ technological innovation presents companies regarding files the way to uniquely marking & recognize each and every actual physical file. This specific guarantees the uniqueness of each file since the technological innovation cannot be modelled and in addition let the authentication on the actual physical file. Involved inside the Bubble Tag™ technological innovation is definitely an anti-falsification solution that allows file companies for you to certify the content on the file hence promising it's ethics.The actual technological innovation might be involved inside the file lifecycle delivering an increased safety measures solution for that manufacturing, personalisation, issuance, control, extension and drawback regarding identity files.

[bilcareresearchtechnologies-blog]

Anti Counterfeit Market for Food and Pharmaceuticals Expected

next Jan 2014 In accordance with a fresh survey statement, ‘Anti Counterfeit Current market for Foodstuff and Medication (2009–2014)’, publicized through Markets and Markets, the actual global anti bogus market place for food and pharmaceuticals market place can be expected to become really worth US$79. 3 million through 2014, having an believed CAGR of 8. 6% from 09 to be able to 2014. This North american market place can be expected to are the cause of just about 62% on the overall income..

Browse greater than 66 market place facts kitchen tables with twenty-two figures multiply via 250 web pages and in-depth TOC about "Anti Counterfeiting Market". http: //www. marketsandmarkets. com/Market-Reports/anti-counterfeit-packaging-advanced-technologies-and-global-market-129. html

Early buyers will probably receive 10% customization for this statement.

Enquiry before Obtaining @http: //www. marketsandmarkets. com/Enquiry_Before_Buying. asp? id=129

Escalating conditions of counterfeiting get generated setup of anti bogus technologies. Anti bogus technologies are of a couple of types namely authentication presentation and observe and search for presentation technologies. America contains a significant reveal on the global anti bogus market place. Asian countries has the best growth rate because of untapped market place and significant higher level of counterfeiting. The european union has a reduce growth rate caused by a reasonably reduce number of cases of counterfeiting.

This global anti bogus presentation market place can be expected to become really worth US$79. 3 million through 2014, rising at approximately CAGR of 8. 6% from 09 to be able to 2014. Clubhouse signal kinds the greatest market place part; and is expected to accomplish US$26 million through 2014. On the other hand, since the tavern signal market place can be reaching readiness it is rising with a suprisingly low CAGR of 0. 4% for that identical period. RFID market place has the best growth likely and is expected to develop with a CAGR of 20. 2% for that identical period.

America would be the major part inside the anti bogus market place and is expected to accomplish US$49 million through 2014, accounting for almost 62% on the income rising with a CAGR of 6. 8%. Asian countries would be the 2nd major market place and is expected to accomplish US$14 million through 2014 with a best CAGR of nineteen. 7%.

[bilcareresearchtechnologies-blog]

Good times ahead for pharma packaging

Your pharma packaging market in India is fast moving on the development ladder with several growth drivers like establishment of several small and huge product manufacturing and processing industries coming up at a larger scale. Moreover, since several pharma companies tend to be exporting their products on the overseas markets they may be adopting high degree packaging standards on par while using international standards. In an online interview, SV Krishna Prasad, BOSS & Director, Cito Professional medical (P) Ltd, sheds light for the growth prospects on the Indian packaging industry and shares information on various aspects associated with packaging with Amguth Raju.

How will you view the pharma appearance industry in India? Could you give your perspective in regards to the prospects of this packaging sector in the united states? Indian pharma packaging will assume a greater importance inside the times to occur, as we are having one of several world’s biggest and growing pharmaceutical industries consisting of huge packing/packaging needs for bulk drugs, formulations, diagnostic equipments/kits, clinical trial drug packaging specifically for multicentric trials both the investigational drug products along with the analyzable samples associated with plasma, serum for example.

How big industry size for pharma appearance globally is and where does India stand? As each 2011 statistics, this global market size for pharma appearance stood at $34 million. Currently the development of packaging industry in India is moving for a faster pace compared to that of this global sector. In line with Industry forecast simply by 2015, Indian pharma appearance sector is anticipated to be at $50 million

What according to you personally are the important growth drivers regarding pharma packaging? The major drivers attributing on the growth of appearance industry in India include the rise of numerous product processing products, among these foodstuff processing, formulations, bulk drugs and also other related industries include catalyzed the development of packaging market. Moreover many ones are adopting advanced packaging technology to be sure safety, quality and prolonged shelf life on the products. For case in pharmaceutical portion, nano-enabled packaging regarding blisters is widely used. This is planning to grow to $2. 10 billion with the end of 2014.

The pharmaceutical packaging market is constantly advancing and has experienced annual growth of at the least five per dime per annum previously few years. The market is now reckoned to get worth over $20 billion 1 year. As with most other packaged goods, pharmaceuticals need dependable and speedy appearance solutions that deliver a variety of product protection, excellent, tamper evidence, individual comfort and safety measures needs.

How does one view the pharma packaging sector inside the emerging markets? From the emerging markets, India, China and Brazil are fast catching up your of the standards people, Western Europe and Japanese markets. As huge quantities of pharmaceutical products are exported to this advanced countries via India, China and Brazil, it has grown to be imperative for this developing markets to follow the packaging standards on the advanced countries. Because the emerging markets are providing less expensive and standard appearance solutions, many overseas firms are outsourcing the business to nations around the world like India and china for less expensive solutions.

How does one view the responsibility of pharma firms in ensuring this safely packed products reach the finish users? It is high time that all pharma firms realize their responsibility how the packed products these people manufactured reach the finish users safely with no tampering. As most on the Indian pharma merchandise are exported to other countries you have to have adopted foolproof appearance technology. Even the middle government agencies may also be taking steps within ensuring better packing systems to get evolved.

In view associated with stringent regulations it's important pharma companies ensure product as well as packaging is qualitative and compliant, they must ensure safety of the item that is packed as well.

What is the existing estimate of pharma appearance sector in India and the amount of it what people mean about plastic and PVC appearance? The pharma packaging industry in the united states is estimated at around Rs 10, 000 crore. With this, plastics and PVC appearance market is pegged at all-around Rs 4000 crore.

The central govt has formed any panel to ban plastic containers for packaging pharma merchandise. How do people view this and what could possibly be the possible impact if ban comes into force? Over this years pharma firms have increasingly chosen plastic and FURRY FRIEND bottles over glass containers to offer cough syrups, antacids, vitamins as they're advantageous for

break proof, Light fat and reduce wastage On the other hand, banning would be appropriate on the extent that they end in leaching and carcinogenicity that's the major risks being envisioned used of plastic and PET media regarding pharma packaging. Banning is okay but an alternative like blister packs should be encouraged for cessation associated with plastic/PET usage over the pharma industry.

Additionally, as in the way it is of carry carriers regulated now, quality of this poly bag manufactured to your certain micron spec could be a win-win situation inside the sense that key research and expenditure in finding a new method is avoided, also as a cheaper alternative for example.

What precautions need to one take whilst packaging and just what could the possible implications of incorrect packaging? As pharma merchandise are highly reactive and involve life conserving chemicals utmost precautions should be taken as prescribed with the packaging manual for just a particular product. Improper packaging could produce many safety ramifications.

Impact could be such that an improper packaging could cause container loads associated with pharma materials getting stuck and be returned.

[bilcareresearchtechnologies-blog]

bilcare-ltd chairman speech

Pricey Investors,

Ex- Web design manager associated with The indian subcontinent, Delayed Medical professional. APJ Abdul Kalam often used to estimate "You will never be offered some sort of dream with no capacity to ensure it is appear true".

Launch in our ''center associated with excellence ''at Pune is usually similar to our previous attached to thoughts together with Medical professional. Kalam. Even as keep in mind your pet, we all in addition attract huge perception associated with motivation together with aspiration. Enthusiasm to help remain against all-round issues when they come through in addition to aspiration for being a impactful chief in this industry, whilst beating just about all impediments.

Long before, Bilcare create the international footprints in the formulated overall economy, that had some sort of eye-sight for being international chief, in addition to within the process, that pursued some sort of dream of which embodies Medical professional. Kalam''s idea.

In numerous event, I had created the chance to look for the suggest in addition to blessings- large quantity source of inspiration, which served you within acquiring forwards a few of our innovation about pill dishing out in addition to ncID™ Engineering.

Bilcare usually checked out pharma product packaging from the medical, analysis angle, which in turn not just served you to be a leading in many pill dishing out technological know-how but shielded most of these enhancements together with international patents, which served you for being in front of the necessities, whilst generating our dream become a!

Bilcare Investigation AG (BRAG), composed associated with pharma, niche in addition to cards product packaging business in the us, The european countries and after this Parts of asia, which in turn make up a lot more than eighty % associated with Company''s entire profit is usually ''Gaining Momentum'' to help come through as critical expansion new driver to the Business, indicating powerful turnover expansion in addition to margin progress in the present season. BRAG''s Profit has enhanced by EUR 240 Mn. within (2011/12) to help EUR 265 Mn. within (2014/15), existing season, even with quit by product packaging business worth EUR 50 Mn. Similarly, BRAG EBIDTA is usually in place by EUR 8 Mn. within (2011/12) to help EUR 28 Mn. within (2014/15) on account of advisable tactic setup, charge proficiency in addition to replanning associated with business in addition to products.

BRAG business having consolidated in addition to gained management situation in the us in addition to The european countries, is currently looking to expand in addition to engage excessive likely Hard anodized cookware areas. Bilcare Investigation AG received Bilcare Singapore pharma product packaging property in addition to aimed to help the Western in addition to PEOPLE business design to be a healthy method, and to expand the customer bottom within Where you live now China and taiwan, and other Hard anodized cookware areas, generating Singapore for Hard anodized cookware Centre.

Additionally it is possible to say of which BRAG, a simple rising business is usually well borrowed simply by foremost Western financial institutions together with secure repayment- presenting more traction intended for expansion within gross sales in addition to margins.

In volume extension prefer to infuse expansion in addition to meet customer prerequisite, BRAG is usually along the way associated with investing 15 Zillion Pound at the manufacturing web page Staufen, Philippines, in which Bilcare is usually been identified for some time to be a powerful in addition to dedicated companion in the shrink movies marketplace.

Each of our final couple of years in another country restructuring work out has catapulted to help visible consequence this season and also this trend will continue in the following decades.

Bilcare is constantly on the devote about R&D actions in addition to effectively use the assets made about generation associated with analysis websites producing profitable addition associated with more modern products, techniques companies in addition to technological know-how to help the innovation stock portfolio. Over the economic season, Bilcare recorded 2 brand-new Obvious programs linked to the modern products in addition to technological know-how in addition to have been given 9 Patents, previously applied.

Bilcare R&D received state-of-the-art within establishing lightweight substance that can come with an excellent filter intended for ''Nuclear Radiation''. DRDO took his or her first prototype demo using this substance and also have placed a get to the same.

Bilcare GCS clocked 12. 8% Profit expansion together with addition associated with 15 new business. ''Comparator Sourcing'' business enhanced substantially over recently, exhibiting 40% expansion. Using expansion in addition to improving customer prerequisite in the gulf, GCS opened up advertising and marketing office buildings within USA in addition to BRITISH to help catch potential prospect. Many of us count on marketing ebay department to help corner INR 100 Cr. simply by following season.

Bilcare Engineering made inroads within bagging pharma in addition to Federal clients in addition to essential pilot assignments. Dealing with pharma, there was clearly range integration undertaking intended for serialization companies intended for key, secondary & tertiary degree product packaging intended for Biocon, as well as way to obtain secondary in addition to tertiary labeling. Similarly, we all could actually do serialization in addition to monitor in addition to find as per DGFT & MoHFW requirement intended for secondary in addition to tertiary delivers intended for Merck at Fulford The indian subcontinent Ltd in addition to Body about The indian subcontinent.

A new paradigm adjust within Bilcare ncID Engineering is usually required to end up being let loose together with induction associated with extremely skilled technocrat; who along with his ''new team'' is usually taking care of go-to- the-market tactic together with customer focused solution offerings.

Financial records:

Overall Standalone Profit to the season diminished by INR 394. forty seven Cr. within (FY14) to help INR 335. 59 Cr. within (FY15).

That decrease of gross sales is usually mostly because of meltdown within doing work investment capital in conjunction with reduction and unfulfillment associated with instructions, or even within different words- we to help forgo instructions on hand on account of natural substance unavailability intended for stated factors. That led to lessened EBIDTA associated with INR 20. up to 29 Cr. in the present season, (FY15) by INR 57. 49 Cr. on the prior season, (FY14).

Increase within accounting allowance by INR 67. 80 Cr. within (FY14) to help INR 105. fifty two Cr. within (FY15) brought about further enhance associated with INR thirty seven. 71 Cr. on account of change within Company''s react 2013, producing World wide web Decrease in INR 183. 68 Cr. to the season, (FY15).

On the other hand, Profit to the one fourth was over, (Q4 FY15) was at INR three months. forty-eight Cr. as against INR 81. of sixteen Cr. on the prior one fourth (Q3 FY15), exhibiting an improvement associated with 15. 76%

Overall Combined Profit to the existing season was over, (FY15) lessened to help INR 2737. 88 Cr. as against INR 3075. 66 Cr. on the recently (FY14) together with EBIDTA% partially in place by 8. 35% to help 8. 44%.

"Failure will not overtake everyone in the event my own description to ensure success is usually powerful enough" this particular saying associated with Medical professional. Kalam is perhaps many apt, once i think about The indian subcontinent Small business.

When conscious, The indian subcontinent Small business within final couple of years within dealing with particular stress on account of mismatch associated with cash flows- influencing natural substance procurement in addition to getting together with customers'' instructions on hand, subsequently our leading in addition to net profit has endured to a huge level.

We have now worked tough to fulfill our financial institution motivation – together with pretty much 60% resolution associated with personal debt by means of several possibilities in addition to structures permissible under consumer banking structure. I am comfortable to turn all around headwinds, by means of our constant, group, belligerent undertaking, looking at just about all feasible possibilities.

Using BRAG business exhibiting visible sign associated with traction, with The indian subcontinent personal debt under fast resolution, We are comfortable that your particular Business can rapidly come out by boulevard associated with the strong beyond to a far better in addition to shiny potential in the coming financial season.

When i determine, may possibly My spouse and i, on behalf of your own Mother board associated with Owners as well as the workers of the Business, yet again thanks a lot on your carried on assist in addition to reassurance.

Thanks a lot, Girls & Guys.

Mohan H. Bhandari

Chairman & Controlling Movie director.

[bilcareresearchtechnologies-blog]

The increase in self-administered Therapies

Decades ago, healthcare revolved around hospital care. Today, healthcare often revolves around the home - a situation that has largely resulted from cost constraints and the introduction of maintenance-type drugs for treating chronic conditions such as arthritis, cancer, multiple sclerosis, and other diseases that require frequent medication. Many of these maintenance therapies are delivered by injection, spurring a need for patient-friendly administration systems. Bilcare ltd ensure the potency of the drug, be tamper-evident, help deter counterfeiting, promote compliance with a dosing regimen, ensure dosing accuracy, and be as safe, easy to use and painless as possible.

An outgrowth of these changes is the move from the typical vial and disposable syringe to the prefillable syringe. With prefillables, dosing accuracy is ensured but they present some challenges for the industry. A pharmaceutical company needs a prefillable system that protects the integrity of the packaged drug product over time and will function as represented over the full shelf life of the drug product. The response from component manufactures was to develop syringe plungers with barrier films that minimize the interaction between the packaged drug and the components. At the same time, the industry has developed elastomers for molded plungers that maintain functional properties such as seal integrity, and break-loose and extrusion forces.

When self-administered drugs are in lyophilized or dry powder form, manufacturers must find methods or pharma packaging systems that help prevent accidental needle stick injuries, inaccurate dosing, and drug spray-back. Manufacturers familiar with the drug administration process must provide delivery systems that simplify drug reconstitution, especially for non-professional caregivers.

What's next?

Packaging solution and delivery systems as a differentiator for drug products will continue to become more important, especially in crowded therapeutic areas and for solving industry-wide problems such as drug-product counterfeiting. Bilcare is receptive to packaging systems that can provide track-and-trace capabilities and product authentication throughout the supply chain. Pharmaceutical seals are an ideal platform for these technologies. 

.

[bilcareresearchtechnologies-blog]

Mass effect of smart packaging

Growth in generics and CROs in the Asia-Pacific region, especially in China and India, which are emerging as most sought-after markets, will increase the adoption of smart packaging to improve traceability across supply chains and prevent counterfeiting by increasing the utilization of RFID tags and chips connected to cloud-based monitoring systems.

The futureappearss promising for smart pharma packaging in the pharmaceutical industry, but there are still many hurdles for it to clear before it is adopted on a wider scale, one of which is cost.  Smart packaging isn't cheap: the entire system, from the choice of material to production and storage, is expensive compared with conventional packaging and the extent to which this will be handed on to consumers is a major issue.

Concentrating on developing items that can be used across segments will help controlcostst.  A main advantage of smart pharma packaging is that it enables the producer to choose whether the pharma packaging should be developed for an entire product line, or on a case-by-case basis.  Another key issue is that packaging is frequently crucial to a drug's success, so careful planning and choice of materials, design, equipment and processing is vital.

From an industrial perspective, smart packaging can result in increased collaboration between technologysupplierss and packaging manufacturers, which will help market growth.  It will also introduce new stakeholders, such as electronic component producers and IT service providers, into the value chain, changing the industry's dynamics. The most important factor in the success or otherwise of smart packaging is its ability to inspire consumer confidence and thereby gain acceptance.

The pharma packaging industry Bilcare Ltd is increasingly investing in the pharma packaging innovation and smart packaging is one way to smooth this rapid transition. It isn't close to reinventing the wheel, but rather driving pharma towards a patient-centric approach that provides consumers with the means and devices to improve their ability to access and use products

[bilcareresearchtechnologies-blog]

Eco-Friendly Pharmaceutical Packaging Solutions

Quality assessment is one of the most crucial aspects in the pharmaceutical industry. The evaluation of quality and operational excellence of a pharmaceutical organization is an important factor which has a direct impact on the selection of prospective contract manufacturing partners. Bilcare, a prominent name in the pharma packaging industry highlights the essential factors for quality assessment in pharma industry. Consistency and good overall structure are the factors which determine the effectiveness and working process of an organization.

Medical and pharmaceutical sector is one of most crucial sectors in society. It has a major role in ensuring the well being of society. However, counterfeiting of products has become a major concerning issue in this sector. In order to cut down the cost, the manufacturers compromise with the quality of products.   These counterfeited products are a threat to the pharmaceutical industry and the society. They have an adverse effect on the health of the consumers

Most companies today are looking for ways to run a leaner, more efficient packaging operation. Good designs reduce costs and improve durability; rising energy and paper costs make eco-friendly packaging more appealing to the pharmaceutical industry because of its cost efficiency. Plus, switching to reusable and recyclable packaging (without compromising safety or accessibility) is an important contribution to the health of our environment.

Pharmaceutical manufacturers can save money and offer better protection for products just by choosing the right pharmaceutical packaging design solutions. Whatever your shipping and packaging needs are, Bilcare   has the flexibility and tools to handle them in the most cost-effective and patient-compliant methods while ensuring efficiency and accuracy.

[bilcareresearchtechnologies-blog]

Radiopharmaceutical Handling and Packaging

Packaging is defined as the collection of different components which surround the pharmaceutical product from the time of production until its use. Pharma packaging products is a broad, encompassing, and multi-faceted task. At Bilcare Packaging is responsible for providing life-saving drugs, medical devices, medical treatments, and new products like medical nutritionals in every imaginable dosage form to deliver every type of supplement, poultice, liquid, solid, powder, suspension, or drop to people the world over. It is transparent to the end user when done well and is open to criticism from all quarters when done poorly.

Distribution of products is now more global than ever. Mass customization of packaging to permit its use in multiple markets is a topic that needs exposition and discussion. Environmental issues, including sustainability, will always be a subjective dimension to any packaging design. Pharma Packaging is an emerging science, an emerging engineering discipline, and a success contributor to pharmaceutical industries.

Packaging can reside, or report through research and development (R and D), engineering, operations, purchasing, marketing, or the general administrative department of a company. For the majority of products produced in Bilcare it is probably the single largest aggregate purchase made by a company of materials critical to the protection, distribution, and sale of the product.

Radiopharmaceuticals, if handled incorrectly, can compromise exams and consequently the health of many people. With the intention of renewing radiopharmaceuticals Follow a branding study developed by Brand, the team had the challenge of bringing graphic elements while respecting the national regulations of the segment, in addition to study the security seals and talking to doctors and other professionals who handle these products daily, in order to make the new packaging more practical and safe.

Packaging is defined as the collection of different components which surround the pharmaceutical product from the time of production until its use. Pharma Packaging products is a broad, encompassing, and multi-faceted task. Packaging is responsible for providing life-saving drugs, medical devices, medical treatments, and new products like medical nutritionals in every imaginable dosage form to deliver every type of supplement, poultice, liquid, solid, powder, suspension, or drop to people the world over.

[bilcareresearchtechnologies-blog]

Use of Holograms and Anticounterfeiting Approaches

The success and near universal use of holograms in anticounterfeiting uses has unavoidably led to attempts to copy or replicate them. The essential topographies of holograms, however, are very difficult to copy with 100% accuracy which makes them an ideal revealing feature for packaging. The growing role of the hologram has also been accompanied by enlarged use of the security device in grouping with other verification technologies. In such solutions, holograms can provide obvious first-line verification while covert features such as scrambled images, microtext, UV-sensitive or other specialist inks provide second line verification for trained surveyors and appropriate interpreting equipment.

The World Health Organization estimates that annual incomes from the worldwide sales of fake and substandard drugs are more than $32 billion. Both drugs and packaging are faked and people's lives have been put at risk. Deviation of authentic products outside approved distribution channels is another issue. To struggle these problems, many of the world's leading medical companies have directed efforts toward validating their packaging as part of the process of shielding their merchandises. Diffractive optically variable devices—referred to generically as holograms—have become a widely used overt authentication feature on medical merchandises worldwide.

Another recent trend is the serialization of holograms as part of systems that combine authentication with traceability. These "track-and-trace" systems link on-pack security devices with database management and field-tracking services. Manufacturers are able to tell where a pharmaceuticals consignment has been, where it's located, and where it's headed. This is particularly important in identifying the source and provenance of products.

It is important to note, however, that it is the primary responsibility of manufacturers and regulators to ensure that fake pharmaceuticals not be able to enter the legitimate supply chain. A case in point occurred in Southeast Asia where it has been reported that more than half the sales of the antimalaria treatment Artesunate were for counterfeit versions despite the drug's blister-pack that contained a hologram. The point is, although regulators can identify fake holograms, the public cannot necessarily do so. Going forward, holograms will continue to evolve and for the time being, remain an integral part of anticounterfeiting approaches.

[bilcareresearchtechnologies-blog]

Bilcare Pharma Packaging Strategy

Packaging is defined as the collection of different components which surround the pharmaceutical product from the time of production until its use. Pharma packaging products is a broad, encompassing, and multi-faceted task. At Bilcare Packaging is responsible for providing life-saving drugs, medical devices, medical treatments, and new products like medical nutritionals in every imaginable dosage form to deliver every type of supplement, poultice, liquid, solid, powder, suspension, or drop to people the world over. It is transparent to the end user when done well and is open to criticism from all quarters when done poorly.

Distribution of products is now more global than ever. Mass customization of packaging to permit its use in multiple markets is a topic that needs exposition and discussion. Environmental issues, including sustainability, will always be a subjective dimension to any packaging design. Pharma Packaging is an emerging science, an emerging engineering discipline, and a success contributor to pharmaceutical industries. Packaging can reside, or report through research and development (R and D), engineering, operations, purchasing, marketing, or the general administrative department of a company. For the majority of products produced in Bilcare it is probably the single largest aggregate purchase made by a company of materials critical to the protection, distribution, and sale of the product.

[bilcareresearchtechnologies-blog]

Bilcare's Pharma Packaging Innovations

The deep customer relationships with the Who’s Who of pharma giants give Bilcare a critical advantage that will benefit them in the long term through cross selling of Bilcare’s patented Pharma Packaging Solutions to global players. They believe Bilcare will become a dominant player in the pharma packaging industry globally in three aspects: market (customer) leadership, geographic reach, and product & solutions offerings.

Currently, Bilcare is collaborating with global pharmaceutical companies to ensure market competitiveness for their products through brand protection, brand management and brand enhancement strategies in addition to their Optima® services, Brandpack® - Innovative design solutions and 5C approach of strategic consulting in pharma packaging material sciences. This represents Bilcare’s radical shift in the pharma packaging space and is a vital step towards delivering state-of-art innovations and establishing a global leadership position in the industry. Their key strategy is to push high margin products and solutions thereby positively contributing to the overall business growth.

Bilcare provides brand protection and better control over the movement of a product across the value/ supply chain through its nonClonableID® technology which also empowers retailers and consumers with an easy to use real time means for product verification.

Their aluminum foils, polymer films and anti-counterfeiting packaging solutions make us a force to reckon in the packaging industry and we remain a dominant player in the blister packaging market. Rapid advances in the pharmaceutical industry require innovative packaging solutions. Their material science experts create exclusive packaging with barrier properties and convenience features to protect the quality and integrity of pharmaceutical products at optimal cost. Bilcare now aggressively focuses on its key business strategy of providing Solution based packaging material through its unique 5C program that addresses the key challenges of – Counterfeiting, Compliance, Communication, Convenience and Child Resistant packaging materials.